ALNYLAM PHARMACEUTICALS, INC.

MA

Biopharmaceutical company.

Filings
13
Firms Hired
1
Total Expenses
—
Years Active
2020–2022

Filings

All 202220212020
YearFirmPeriodExpensesDoc
2022 WELSH ROSE, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination 		—
2022 WELSH ROSE, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2022 WELSH ROSE, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2021 WELSH ROSE, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2021 WELSH ROSE, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2021 WELSH ROSE, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2021 WELSH ROSE, LLC 1st Quarter (Jan 1 - Mar 31)
AMENDED 		—
2021 WELSH ROSE, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2020 WELSH ROSE, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2020 WELSH ROSE, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
Page 1 of 2  ·  13 filings Next
Firms Hired
FirmFilingsExpenses
WELSH ROSE, LLC 13 —
Issue Areas
IssueActivities
Medicare/Medicaid 13
Health Issues 1

Bills Mentioned in Filings

H.R. 748 S. 3548 H.R. 133 H.R. 4178